Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report) shares passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.
Arno Therapeutics Price Performance
About Arno Therapeutics
Arno Therapeutics, Inc, a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men.
Recommended Stories
- Five stocks we like better than Arno Therapeutics
- Health Care Stocks Explained: Why You Might Want to Invest
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- How to Capture the Benefits of Dividend Increases
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Consumer Discretionary Stocks Explained
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
